MP58: Prostate Cancer: Localized: Surgical Therapy III
221C
Poster and Podium Sessions
Oncology: Prostate
Information
Continuing Medical Education
CME
Sunday, May 5
MP58-01: A Randomized Controlled Trial of a Fermented Soy Beverage Among Patients with Localized Prostate Cancer Prior to Radical Prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-02: Organ-confined pT2 ISUP4/5 vs. non-organ confined ≥pT3 ISUP2/3 prostate cancer: Differences in biochemical recurrence-free survival and metastasis-free survival after radical prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-03: Retzius-sparing robot-assisted radical prostatectomy with the Hugo RAS system: feasibility, operative setup and surgical outcomes
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-05: Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: surgical and functional outcomes
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-06: Urinary Continence Recovery after Retzius-Sparing Robot-Assisted Radical Prostatectomy and Adjuvant Radiation Therapy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-07: Timing of Transversus Abdominis Plane Block (TAP) for Pain Control after Laparoscopic Radical Prostatectomy (LRP)
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-09: Baseline health-related quality of life predicts metastasis-free survival in men with intermediate risk prostate cancer following radical prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-10: Modeling the Oncological Outcomes of Partial Prostatectomy in a Cohort of Patients Who Underwent Radical Prostatectomy for Localized Prostate Cancer
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-11: Gleason grade group 1 prostate cancer volume at biopsy is associated with unfavorable pathology but not upgrading after radical prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-12: Robot-Assisted Single-Port Transvesical Radical Prostatectomy: Initial Findings from Medium-Term Follow-Up
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-13: Long-term biochemical recurrence in patients with lymph node invasion undergoing radical prostatectomy and lymph node dissection.
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-14: Oncological and Functional Outcomes in High Risk and Very High Risk Prostate Cancer Patients Receiving Robotic-Assisted Radical Prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-16: Outcomes of the novel surgical technique preservation of the pelvic stabilized structures robot-assisted radical prostatectomy: A propensity score matching study
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-17: Construction of a predictive model for quality of life in patients after robot-assisted radical prostatectomy
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-18: Does Equal Access mean Equal Access to Secondary Treatments after Biochemical Recurrence (BCR) following Radical Prostatectomy (RP)
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-19: 10 year experience of robotic assisted laparoscopic prostatectomy (RALP) in patients with atypical anatomy and pathology: pre-operative cystoscopy serving as a third eye.
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C
MP58-20: Impact Of Extended Vs Limited Pelvic Lymph Node Dissection On Biochemical Recurrence In Intermediate And High-Risk Prostate Cancer
Sunday, May 5, 2024 1:00 PM to 3:00 PM
221C